NCT06467344: Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 15 planned
- Started
- 11 Jun 2024
- Primary completion
- 1 Aug 2030
- Arms
- Low dose of ACDN-01, Mid-dose of ACDN-01, High dose of ACDN-01
- Results
- None posted
- 11 Jun 2024: Trial started
- 21 Jun 2024: Trial registered